SULT1A3

SULT1A3
SULT1A3 is a gene that encodes for an enzyme belonging to the sulfotransferase family. This enzyme is involved in the sulfation process, which is a crucial step in the metabolism of various compounds in the body. Sulfation is the process of adding a sulfate group to a molecule, often to increase its solubility and facilitate its excretion from the body.
Function[edit]
SULT1A3 is primarily expressed in the liver and plays a key role in the metabolism of drugs, hormones, and xenobiotics. It catalyzes the transfer of a sulfate group from 3'-phosphoadenosine 5'-phosphosulfate (PAPS) to a substrate molecule, resulting in the formation of a sulfate conjugate. This conjugation reaction is essential for the elimination of potentially toxic compounds from the body.
Clinical Significance[edit]
Variations in the SULT1A3 gene can impact individual differences in drug metabolism and response to medications. Polymorphisms in this gene may affect the enzyme's activity, leading to differences in the rate at which certain drugs are metabolized and cleared from the body. Understanding these genetic variations is important for personalized medicine and optimizing drug therapy.
Regulation[edit]
The expression of SULT1A3 can be influenced by various factors, including environmental exposures, hormonal fluctuations, and genetic variations. Regulatory elements in the gene's promoter region control its transcriptional activity, ensuring that the enzyme is produced in the right amounts at the right time.
Interactions[edit]
SULT1A3 may interact with other enzymes involved in drug metabolism and detoxification pathways. These interactions can impact the overall efficiency of the sulfation process and the body's ability to eliminate foreign compounds. Studying these interactions is essential for understanding the broader network of metabolic pathways in which SULT1A3 participates.
References[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
